Citadel Advisors »

Capstone Therapeutics Corporat shares owned by Citadel Advisors

Quarter-by-quarter ownership of Capstone Therapeutics Corporat (CAPS) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Capstone Therapeutics Corporat

Tip: Access up to 7 years of quarterly data

All positions including Capstone Therapeutics Corporat held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Capstone Therapeutics Corporat by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $21k 16k 1.31

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
Strategy Cl A New Call Option (MSTR)
Alphabet Cap Stk Cl A Call Option (GOOGL)
UnitedHealth Call Option (UNH)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)

View all positions for Citadel Advisors

Top funds holding Capstone Therapeutics Corporat

Pensionmark Financial Group
Citadel Advisors
Two Sigma Securities
Two Sigma Investments
Tower Research Capital
UBS Group
Morgan Stanley

View all funds holding Capstone Therapeutics Corporat